dipyridamole has been researched along with pyrroles in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirano, Y; Masuda, N; Satoh, N; Shirai, Y; Taguchi, T; Takenaka, T; Uchida, W | 1 |
| Birnbaum, Y; Huang, MH; Hughes, MG; Lin, Y; Manickavasagam, S; McAdoo, DJ; Perez-Polo, R; Uretsky, BF; Ye, Y | 1 |
| Charles, J; Miller, G; Pan, Y | 1 |
| Fisher, MJ; Liu, S; Paganini-Hill, A; Yang, F; Yu, C | 1 |
| Chen, YT; Chuang, EY; Godugu, C; Jheng, PR; Lee, CY; Liu, CH; Nguyen, HT; Rethi, L | 1 |
5 other study(ies) available for dipyridamole and pyrroles
| Article | Year |
|---|---|
Cardiovascular effects of YM099, a novel K+ channel opener, in anesthetized and conscious dogs.
Topics: Adenosine Triphosphate; Animals; Benzopyrans; Blood Flow Velocity; Blood Pressure; Cardiac Output; Cardiovascular System; Carotid Arteries; Coronary Circulation; Cromakalim; Cyclic N-Oxides; Dipyridamole; Dogs; Dose-Response Relationship, Drug; Female; Femoral Artery; Glyburide; Heart Rate; Injections, Intravenous; Male; Mesenteric Arteries; Nitroglycerin; Oxadiazoles; Potassium Channels; Pyrroles; Renal Artery; Vascular Resistance; Vasodilator Agents | 1994 |
Enhanced cardioprotection against ischemia-reperfusion injury with a dipyridamole and low-dose atorvastatin combination.
Topics: Adenosine; Administration, Oral; Animals; Atorvastatin; Cardiotonic Agents; Dipyridamole; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Heptanoic Acids; Male; Myocardial Reperfusion Injury; Pyrroles; Rats; Rats, Sprague-Dawley; Treatment Outcome | 2007 |
TIAs - management in general practice.
Topics: Anticoagulants; Antihypertensive Agents; Aspirin; Atorvastatin; Clopidogrel; Dipyridamole; Dopamine Antagonists; General Practitioners; Heptanoic Acids; Humans; Hypolipidemic Agents; Ischemic Attack, Transient; Perindopril; Platelet Aggregation Inhibitors; Primary Health Care; Prochlorperazine; Pyrroles; Ticlopidine; Vasodilator Agents; Warfarin | 2010 |
Phosphodiesterase inhibitor modulation of brain microvascular endothelial cell barrier properties.
Topics: Actins; Brain; Capillary Permeability; Carbazoles; Cells, Cultured; Cilostazol; Claudin-5; Dipyridamole; Drug Interactions; Electric Impedance; Endothelial Cells; Histamine; Humans; Isoquinolines; Phosphodiesterase Inhibitors; Protein Kinase Inhibitors; Pyrroles; Rolipram; Sulfonamides; Tetrazoles | 2012 |
P-Selectin mediates targeting of a self-assembling phototherapeutic nanovehicle enclosing dipyridamole for managing thromboses.
Topics: Animals; Dipyridamole; Nanoparticles; P-Selectin; Phototherapy; Polymers; Pyrroles; Thrombosis | 2023 |